Esperion Presents New Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL
DAIC
DECEMBER 3, 2024
18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with Peripheral Artery Disease (PAD) who were unable or unwilling to take statin medications. tim.hodson Tue, 12/03/2024 - 16:52 Nov. These data were presented at the 2024 American Heart Association Scientific Sessions, in Chicago, IL.
Let's personalize your content